Bioradiations Staff
Christopher Buska |
Richard Cuthbert |
Michelle Campbell-Ryan |
| Presented by: |
Christopher Buska, BS, Product Manager & SME-CB, Xybion Digital Inc. Richard Cuthbert, PhD, Global Commercialization Product Manager, Bio-Rad Laboratories, Inc. Michelle Campbell-Ryan, PhD, Regional Flow Cytometry Application Specialist, Bio-Rad Laboratories, Inc. |
|
Available on Demand |
|
These on-demand webinars will provide you with valuable insights and practical knowledge that will help you keep your flow cytometry or drug discovery lab compliant with current regulations. You will learn about the key elements of regulations that apply to flow cytometry and how to implement them, as well as the various stages of drug discovery and the degree of regulation required at each stage. Don’t miss this opportunity to enhance your knowledge and stay ahead in your field. Register now and take the first step toward mastering these essential topics.
An Introduction to U.S. FDA 21 CFR Part 11 for Flow Cytometry
- Understand the regulatory framework and its history
- The importance of data security and integrity
Enabling 21 CFR Part 11 Compliant Flow Cytometry for Laboratories
- How Xybion Compliance Builder Software assists with compliance, including real-time monitoring, file audit and revision management, and electronic signatures
- How Compliance Builder Software can be used in conjunction with the Bio-Rad ZE5 Cell Analyzer
Cytometry in Drug Discovery: An Introduction to Regulation, Standardization, and Productivity
- How each stage of drug discovery is regulated
- How reagent and instrument choice can influence assay standardization and time to results